Dexamethasone Sodium Phosphate NDC 63323-165

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-165Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0165Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-165-16	63323016516	25 VIAL in 1 TRAY (63323-165-16) / 1 mL in 1 VIALMarketed from Sep 7, 2000
63323-165-26	63323016526	25 VIAL, MULTI-DOSE in 1 TRAY (63323-165-26) / 5 mL in 1 VIAL, MULTI-DOSEMarketed from Sep 7, 2000

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone Sodium Phosphate
Generic name (nonproprietary): dexamethasone sodium phosphate
Active ingredients: Dexamethasone sodium phosphate — 4 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 084916
Marketing start: Sep 7, 2000
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 63323-165_9dd90418-e564-4bc5-9077-506a1c2c1bceSPL ID 9dd90418-e564-4bc5-9077-506a1c2c1bceSPL set ID 4fedef4f-ec96-4f36-b2f0-01e243e3b89eRxCUI 1116927, 1812194UNII AI9376Y64PUPC 0363323165161
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323016516 followed by a unit qualifier and the quantity

Package 63323-0165-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 084916

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 084916
Product	Strength	Form · route	Labeler	Product NDC
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	Cardinal Health 107, LLC	55154-9364
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	Sportpharm LLC	85766-269
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	Phlow Corporation	81565-202
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1370
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	A-S Medication Solutions	50090-0414